Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $100000.0.

  • Pulse Biosciences' Depreciation & Amortization (CF) changed 0.0% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $429000.0, marking a year-over-year decrease of 872.34%. This contributed to the annual value of $512000.0 for FY2024, which is 553.51% down from last year.
  • Latest data reveals that Pulse Biosciences reported Depreciation & Amortization (CF) of $100000.0 as of Q3 2025, which was down 0.0% from $100000.0 recorded in Q2 2025.
  • Pulse Biosciences' Depreciation & Amortization (CF)'s 5-year high stood at $200000.0 during Q1 2022, with a 5-year trough of $100000.0 in Q2 2021.
  • For the 5-year period, Pulse Biosciences' Depreciation & Amortization (CF) averaged around $125157.9, with its median value being $112000.0 (2024).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 10000.0% in 2022, then plummeted by 5000.0% in 2023.
  • Pulse Biosciences' Depreciation & Amortization (CF) (Quarter) stood at $151000.0 in 2021, then rose by 19.21% to $180000.0 in 2022, then fell by 23.33% to $138000.0 in 2023, then fell by 18.84% to $112000.0 in 2024, then decreased by 10.71% to $100000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $100000.0 in Q3 2025, compared to $100000.0 in Q2 2025 and $117000.0 in Q1 2025.